Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEG35156 with Carboplatin and Paclitaxel in Advanced NSCLC
NCT00558922Phase 2Terminated
- Sponsor
- Aegera Therapeutics
- Start
- Sep 2007
- Primary completion
- Aug 2009
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of AEG35156 in non-small cell lung cancer (NSCLC), sponsored by Aegera Therapeutics. Started Sep 2007; status: terminated.
02
Drugs
AEG35156
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00558922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558922.